Skip to:

Roshan Bastani



DepartmentsType of Faculty
Health Policy and ManagementFull Time
Contact Information

UCLA Fielding School of Public Health / Department of Health Policy and Management / A2-125 CHS

Roshan Bastani, Ph.D., is a professor in the UCLA Fielding School of Public Health and Director of the UCLA Kaiser Permanente Center for Health Equity and the UCLA Center for Prevention Research. In the Jonsson Comprehensive Cancer Center, she is Director for Disparities and Community Engagement and Associate Director for Cancer Prevention and Control. Her leadership roles also include an 11-year term as Associate Dean for Research in the School of Public Health.

Bastani is a social and health psychologist whose main research interests are in disease prevention and control among disadvantaged groups, with a focus on implementing and rigorously testing individual, community, organization and system-directed interventions to improve access and reduce disparities. She has led a large number of studies targeting low income, ethnic minority and immigrant populations, and has had continuous research funding from the National Institutes of Health since 1988. She has established strong ties with an extensive network of community organizations that serve as partners in her collaborative community research.

Bastani’s research spans the developmental continuum and includes studies on breast, cervix, colorectal and prostate cancer screening and diagnostic follow-up; hepatitis B screening; tobacco control; melanoma prevention; obesity control; liver disease; and HPV vaccine uptake. This work includes examination of the drivers of disparities among underserved groups, implementation of pragmatic intervention trials to mitigate observed disparities and methodological studies, as well as studies to advance theory in the field.

In addition to conducting her own research, Bastani devotes considerable effort to mentoring junior investigators, particularly minority individuals and those interested in research among underserved populations. For over 15 years, she led a National Cancer Institute post-doctoral career development program with a heavy focus on transdisciplinary cancer control training and disparities research.

Selected Publications: 
  • Bastani R, Kaplan CP, Maxwell AE, Nisenbaum R, Pearce J, Marcus AC (1995). Initial and repeat mammography screening in a low income multi-ethnic population in Los Angeles. Cancer Epidemiology, Biomarkers & Prevention, 4(2):161-167. PMID: 7742724
  • Bastani, R., Maxwell, A.E., Bradford, C., Prabhu Das, I., Yan, K. (1999). Tailored risk notification for women with a family history of breast cancer. Preventive Medicine, 29(5): 355-364. PMID: 10564627
  • Bastani R, Berman BA, Belin TR, Crane LA, Marcus AC, Nasseri K, Herman-Shipley N, Bernstein S, Henneman CE (2002). Increasing cervical cancer screening among underserved women in a large urban county health system: Can it be done?  What does it take?  Medical Care. 40(10): 891-907. PMID: 12395023Bastani, R., Yabroff, K.R., Myers, R.E., Glenn, B. (2004). Interventions to improve follow-up of abnormal findings in cancer Screening. Cancer, 101(S5):1188-1200. PMCID: PMC1811062
  • Mojica CM, Bastani R, Boscardin WJ, Ponce NA (2007). Low-income women with breast abnormalities: System predictors of timely diagnostic resolution. Cancer Control, 14(2):176-182. PMID: 17387303
  • Bastani R, Glenn BA, Maxwell AE, Ganz PA, Mojica CM, Chang LC (2008). Validation of self-reported colorectal cancer (CRC) screening in a study of ethnically diverse first-degree relatives of CRC cases. Cancer Epidemiology, Biomarkers & Prevention, 17(4):791-798. PMID: 18381469
  • Bastani R, Glenn BA, Taylor VM, Chen MS, Nguyen TT, Stewart SL, Maxwell AE (2010). Integrating theory into community interventions to reduce liver cancer disparities: The Health Behavior Framework. Preventive Medicine, 50(1-2):63-67. PMCID: PMC3243444
  • Bastani R, Mojica CM, Berman BA, Ganz PA (2010). Low-income women with abnormal breast findings: Results of a randomized trial to increase rates of diagnostic resolution. Cancer Epidemiology, Biomarkers & Prevention, 19(8):1927-1936. PMID: 20647406
  • Maxwell AE, Bastani R, Danao LL, Antonio C, Garcia GM, Crespi CM (2010). Results of a community-based randomized trial to increase colorectal cancer screening among Filipino Americans. American Journal of Public Health, 100(11):2228-2234. PMCID: PMC2951922
  • Bastani R, Glenn BA, Tsui J, Chang LC, Marchand EJ, Taylor VM, Singhal R (2011). Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiology, Biomarkers & Prevention, 20(7):1463-1472.  PMCID: PMC3132826
  • Glenn BA, Bastani R, Maxwell AE, Mojica CM, Herrmann AK, Gallardo NV, Swanson KA, Chang LC (2012). Prostate cancer screening among ethnically diverse first-degree relatives of prostate cancer cases. Health Psychology, 31(5):562-570. PMID: 22708522
  • Tsui J, Singhal R, Rodriguez HP, Gee GC, Glenn BA, Bastani R (2013). Proximity to safety-net clinics and HPV vaccine uptake among low-income, ethnic minority girls. Vaccine, 31(16):2028-2034. PMCID: PMC3629820
  • Tu S, Chun A, Yasui Y, Kuniyuki A, Yip M, Taylor V, Bastani R (2014). Adaptation of an evidence-based intervention to promote colorectal cancer screening: A quasi-experimental study. Implementation Science, 9(85). PMCID: PMC4226971
  • Bastani R, Glenn BA, Maxwell AE, Ganz PA, Mojica CM, Alber S, Chang LC (2015). Randomized Trial to Increase Colorectal Cancer Screening in an Ethnically Diverse Sample of First-Degree Relatives. Cancer, 121(17):2951-9. PMCID: PMC4545725
  • Bastani R, Glenn BA, Jo AM, Herrmann AK, Crespi CM, Wong WK, Chang LC, Stewart SL, Nguyen TT, Chen MS, Taylor VM (2015). Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles. Cancer Epidemiology, Biomarkers & Prevention, 24(9):1341-9. PMCID: PMC4560609
  • Glenn BA, Lin T, Chang LC, Okada A, Wong WK, Glanz K, Bastani R (2015). Sun protection practices and sun exposure among children with a parental history of melanoma. Cancer Epidemiology, Biomarkers & Prevention, 24(1):169-77. PMCID: PMC4295624